Alfarsi, L. H., Ansari, R. E., Erkan, B., Fakroun, A., Craze, M. L., Aleskandarany, M. A., . . . Green, A. R. SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationAlfarsi, Lutfi H., et al. SLC1A5 Is a Key Regulator of Glutamine Metabolism and a Prognostic Marker for Aggressive Luminal Breast Cancer. Nature Portfolio.
MLA (9th ed.) CitationAlfarsi, Lutfi H., et al. SLC1A5 Is a Key Regulator of Glutamine Metabolism and a Prognostic Marker for Aggressive Luminal Breast Cancer. Nature Portfolio.
Warning: These citations may not always be 100% accurate.